These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 12566700)

  • 1. Autoantibodies to CD69 in patients with chronic hepatitis type C: a candidate marker for predicting the response to interferon therapy.
    Okamoto N; Yotsuyanagi H; Ooka S; Matsui T; Suzuki Kurokawa M; Suzuki M; Iino S; Nishioka K; Kato T
    Intervirology; 2003; 46(1):56-65. PubMed ID: 12566700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-CD69 autoantibodies cross-react with low density lipoprotein receptor-related protein 2 in systemic autoimmune diseases.
    Yu X; Matsui T; Otsuka M; Sekine T; Yamamoto K; Nishioka K; Kato T
    J Immunol; 2001 Jan; 166(2):1360-9. PubMed ID: 11145721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies to low-density-lipoprotein-receptor-related protein 2 (LRP2) in systemic autoimmune diseases.
    Ooka S; Matsui T; Nishioka K; Kato T
    Arthritis Res Ther; 2003; 5(3):R174-80. PubMed ID: 12723989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human intrahepatic CD69 + CD8+ T cells have a tissue resident memory T cell phenotype with reduced cytolytic capacity.
    Stelma F; de Niet A; Sinnige MJ; van Dort KA; van Gisbergen KPJM; Verheij J; van Leeuwen EMM; Kootstra NA; Reesink HW
    Sci Rep; 2017 Jul; 7(1):6172. PubMed ID: 28733665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha.
    Alvarado Esquivel C; Elewaut A; Philippé J; Elewaut AE; Desombere I; Maertens G; Leroux-Roels G
    Rev Invest Clin; 2002; 54(1):41-50. PubMed ID: 11995406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection and the production mechanism of antinuclear antibodies (ANA) and anti-liver/kidney microsomal tpe 1 antibodies (anti-LKM1) in patients with chronic hepatitis C].
    Bai L; Lu HY; Feng ZR; Yu M; Li WG; Gong WB; Zhao NE; Xu XY
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Aug; 23(4):278-81. PubMed ID: 20108773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression profiling of peripheral-blood mononuclear cells from patients with chronic hepatitis C undergoing interferon therapy.
    Tateno M; Honda M; Kawamura T; Honda H; Kaneko S
    J Infect Dis; 2007 Jan; 195(2):255-67. PubMed ID: 17191171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Investigation of autoimmunity markers during interferon alpha therapy of chronic hepatitis B and C - twenty years of experience].
    Orságová I; RoŽnovský L; Petroušová L; Konečná M; Kabieszová L; Martinek J; Kloudová A; Pavliska L
    Klin Mikrobiol Infekc Lek; 2016 Jun; 22(2):61-7. PubMed ID: 27450524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celiac disease and non-organ-specific autoantibodies in patients with chronic hepatitis C virus infection.
    Ruggeri C; La Masa AT; Rudi S; Squadrito G; Di Pasquale G; Maimone S; Caccamo G; Pellegrino S; Raimondo G; Magazzù G
    Dig Dis Sci; 2008 Aug; 53(8):2151-5. PubMed ID: 18231858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cells display impaired responses to toll like receptor 9 that support viral persistence in chronic hepatitis B.
    Ratnam DT; Sievert W; Visvanathan K
    Cell Immunol; 2012 Sep; 279(1):109-15. PubMed ID: 23123793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies in chronic liver disease.
    Ghonaim M; Al-Ghamdi A; El-Bana H; Bakr A; Ghoneim E; El-Edel R; Hassona M; Shoeib S; Allam H
    Egypt J Immunol; 2005; 12(2):101-11. PubMed ID: 17977215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
    Wu CH; Xu XY; Tian GS; Yu YY
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a major epitope by anti-interferon-γ autoantibodies in patients with mycobacterial disease.
    Lin CH; Chi CY; Shih HP; Ding JY; Lo CC; Wang SY; Kuo CY; Yeh CF; Tu KH; Liu SH; Chen HK; Ho CH; Ho MW; Lee CH; Lai HC; Ku CL
    Nat Med; 2016 Sep; 22(9):994-1001. PubMed ID: 27525523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and clinical relevance of serum autoantibodies in patients with chronic hepatitis C.
    Chen CH; Lee CM; Chen CH; Hu TH; Wang JH; Hung CH; Chung CH; Lu SN
    Chang Gung Med J; 2010; 33(3):258-65. PubMed ID: 20584503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effects of pegylated interferon plus ribavirin in chronic hepatitis C patients with occult hepatitis B virus dual infection.
    Chen LW; Chien RN; Yen CL; Chang JJ; Liu CJ; Lin CL
    J Gastroenterol Hepatol; 2010 Feb; 25(2):259-63. PubMed ID: 19817959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C.
    Muratori P; Muratori L; Guidi M; Granito A; Susca M; Lenzi M; Bianchi FB
    Clin Infect Dis; 2005 Feb; 40(4):501-7. PubMed ID: 15712070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence, clinical features and response to antiviral therapy of patients with chronic hepatitis C who are seropositive for liver-kidney microsome type 1 antibodies.
    Monti V; Aghemo A; Rumi MG; Donato MF; Del Ninno E; Colombo M
    Antivir Ther; 2005; 10(6):715-20. PubMed ID: 16218170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of antinuclear and anti-liver-kidney-microsome type-1 antibodies in patients with chronic hepatitis C in China.
    Bai L; Feng ZR; Lu HY; Li WG; Yu M; Xu XY
    Chin Med J (Engl); 2009 Jan; 122(1):5-9. PubMed ID: 19187609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organ-specific autoimmunity and genetic predisposition in interferon-treated HCV-related chronic hepatitis patients.
    Floreani A; Chiaramonte M; Greggio NA; Fabris P; De Lazzari F; Naccarato R; Betterle C
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):71-6. PubMed ID: 9615270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.